Sim&Cure

company

About

Sim&Cure develops the medical software Sim&Size® to optimize the choice of endovascular devices for the treatment of cerebral aneurysm.

  • 11 - 50

Details

Last Funding Type
Series A
Last Funding Money Raised
€3M
Industries
Health Care,Medical Device,Software
Founded date
Jan 1, 2014
Number Of Employee
11 - 50
Operating Status
Active

Sim&Cure is the first company to be cleared to market a patient-based simulation model for aneurysm treatment that allows prediction of the deployment of medical devices (flow diverter, intrasaccular device, laser-cuter stent). Sim&Size® simulates each size and type of device according to the patient’s unique anatomy in order to provide essential information prior to the choice of sizing.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
€3M
Sim&Cure has raised a total of €3M in funding over 2 rounds. Their latest funding was raised on May 23, 2019 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 23, 2019 Series A €3M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Sim&Cure is funded by 1 investors. IT Translation are the most recent investors.
Investor Name Lead Investor Funding Round
IT Translation Series A